Search clinical trials for: BH3120
Total 85 results
-
Hanmi Pharmaceutical Company LimitedRecruitingAdvanced or Metastatic Solid TumorsKorea, Republic of, United States
-
ARCAGY/ GINECO GROUPCompleted
-
Novartis PharmaceuticalsCompletedPI3K Pathway Activated TumorsUnited States
-
Novartis PharmaceuticalsNovartisWithdrawnTreatment for Metastatic or Locally Advanced Cervical CancerBrazil
-
Prince of Songkla UniversityTerminatedEsophageal CancerThailand
-
Novartis PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterNovartisCompleted
-
Hospices Civils de LyonUnknown
-
Sofia Perea, Director Clinical Trials Unit.NovartisCompleted
-
Fondazione MichelangeloCompleted
-
Won KimNovartisTerminated
-
Novartis PharmaceuticalsCompletedAdvanced Endometrial CancerBelgium, France, Italy, Canada, Spain, Australia, Germany, United States, Japan, Brazil, Singapore, Russian Federation, Poland
-
Dana-Farber Cancer InstituteCompleted
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular LymphomaUnited States, Belgium, Germany, France, Italy, Korea, Republic of, Spain, Turkey
-
Memorial Sloan Kettering Cancer CenterNovartisCompletedLymphoma | Primary Central Nervous System Lymphoma | Recurrent/Refractory Secondary Central Nervous System LymphomaUnited States
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung CancerFrance, Italy, United Kingdom, Hungary, Belgium, Canada, Spain, Germany, Singapore, Netherlands, Thailand, United States, Turkey, Argentina, Brazil, Hong Kong, Japan, Taiwan
-
Patrick Joseph Loehrer Sr.Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedAdvanced Breast Cancer, Advanced Carcinomas With Squamous Cell HistologyChina
-
Novartis PharmaceuticalsCompletedHepatic ImpairmentGermany, Russian Federation, Bulgaria
-
SOLTI Breast Cancer Research GroupDana-Farber Cancer Institute; Novartis Pharmaceuticals; Stand Up To CancerCompletedBreast CancerUnited States, Spain
-
Massachusetts General HospitalNovartis PharmaceuticalsWithdrawnBreast Cancer | Colorectal Cancer | Lung Cancer | Cholangiocarcinoma | Solid Tumors
-
Anne ChangNovartis PharmaceuticalsTerminatedCarcinoma, Basal Cell | Skin Neoplasms | Basal Cell Nevus Syndrome | Recurrent Skin CancerUnited States
-
Yonsei UniversityUnknownHead Neck Cancer Squamous Cell Recurrent | Head Neck Cancer Squamous Cell MetastaticKorea, Republic of
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma | Transformed Recurrent Non-Hodgkin LymphomaUnited States
-
Novartis PharmaceuticalsCompletedRenal ImpairmentCzechia, Germany, Romania, Bulgaria
-
Array Biopharma, now a wholly owned subsidiary...CompletedAdvanced Solid Tumors | Selected Solid TumorsUnited States, Germany, Canada, Spain, Netherlands, Singapore, Switzerland
-
Patrick Y. Wen, MDM.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Massachusetts... and other collaboratorsCompleted
-
Novartis PharmaceuticalsCompletedBreast CancerCanada, Italy, Czechia, United States, Belgium, Austria, Germany, Spain, Japan, Lebanon, Australia, Bulgaria, Israel, Netherlands, Colombia, Hong Kong, Brazil
-
Novartis PharmaceuticalsTerminatedc-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBMSpain, Switzerland, Germany, United States, Netherlands
-
Andrew J. Armstrong, MDNovartis PharmaceuticalsTerminatedProstate Cancer | Metastatic (Spread to Other Areas of the Body)United States
-
Shanghai Synergy Pharmaceutical Sciences Co., Ltd.Not yet recruiting
-
Novartis PharmaceuticalsCompletedMetastatic Colorectal Cancer | Gastric Cancer | Advanced Solid Tumors | Metastatic Breast Cancer | Gastroesophageal Junction Cancer | Recurrent Glioblastoma Multiforme | Advanced Pancreatic Adenocarcinoma | Safety | Triple Negative Metastatic Breast Cancer | Dose Escalation | Preliminary Efficacy | Hormone Receptor...Canada, United Kingdom, Spain, Germany, Italy, Belgium, Australia, United States
-
Novartis PharmaceuticalsIncyte CorporationTerminatedMyelofibrosisSpain, United Kingdom, Australia, Israel, Germany, Italy, Singapore, Austria, France
-
Novartis PharmaceuticalsCompletedBreast Cancer | Ovarian Cancer | Colon Cancer | Endometrium CancerCanada, Netherlands, Spain, United States
-
Centre Leon BerardNational Cancer Institute, France; Fondation ARCCompletedHead and Neck Neoplasms | Neoplasm Metastasis | Progressive Disease | Recurrent DiseaseFrance
-
Memorial Sloan Kettering Cancer CenterNovartis Pharmaceuticals; Sai Life SciencesCompletedSolid TumorsUnited States
-
Novartis PharmaceuticalsCompletedGlioblastomaAustralia, Spain, Canada, United States
-
Institut Paoli-CalmettesSuspended
-
Novartis PharmaceuticalsCompletedBreast CancerBelgium, France, Taiwan, Hungary, Germany, Singapore, Austria, Netherlands, Australia, Russian Federation, Spain, Canada, Israel, Japan, Korea, Republic of, Italy, United States, United Kingdom, Brazil, Hong Kong, Czech Republic, South...
-
Novartis PharmaceuticalsBreast International Group; German Breast Group; SOLTI Breast Cancer Research...CompletedHER2-positive Newly Diagnosed, Primary Breast CancerAustria, Spain, Australia, Germany
-
University of UtahNovartisWithdrawnEndometrial CancerUnited States
-
University of OxfordNovartis; Cancer Research UKCompleted
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, China, Belgium, Canada, France, Italy, Taiwan, United Kingdom, Hungary, Australia, Spain, Germany, Singapore, Austria, Japan, Israel, Russian Federation, Korea, Republic of, Thailand, Slovakia, South Africa, Switzer... and more
-
Novartis PharmaceuticalsCompletedCastration-resistant Prostate CancerFrance, Spain, Canada, Belgium, United Kingdom, United States
-
Canadian Cancer Trials GroupPfizerCompletedMetastatic Colorectal CancerCanada
-
PfizerCompletedMelanomaUnited States, Australia, Canada, Germany, Italy, Netherlands, Spain, Switzerland, United Kingdom
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyWithdrawnOvarian Cancer | Endometrial Cancer | Recurrent Endometrial Cancer | Recurrent Ovarian Cancer
-
Novartis PharmaceuticalsCompletedPre-menopausal Breast Cancer | PI3K Pathway InhibitionTaiwan, Hong Kong, Thailand, Korea, Republic of
-
Dana-Farber Cancer InstituteNovartis; AstraZenecaCompleted
-
Novartis PharmaceuticalsTerminatedMetastatic Breast CancerUnited States, Germany, Belgium, Canada, France, Italy, Spain, United Kingdom, Austria, Argentina, Sweden, Hungary, Korea, Republic of, Lebanon, Bulgaria, Greece, Thailand, Netherlands, Colombia, Norway, Finland, Poland